



















➤ For more information on vaccines,Understanding the Vaccine Adverse  
Event Reporting System (VAERS) 
vaccine-preventable diseases, and 
vaccine safety: 
http://www.cdc.gov/vaccines/conversations 
Last updated Februar y 2013 
●	 The Vaccine Adverse Event Reporting System 
(VAERS) is one component of the United States’ 
comprehensive vaccine safety monitoring system. 
● VAERS reports are monitored carefully by the  
Centers for Disease Control and Prevention (CDC) 
and the Food and Drug Administration (FDA). 
● Reports of adverse events (possible side effects) 
after vaccination do not mean that the reported 
problem was caused by a vaccine. Reports are 
signals that alert scientists of possible cause-and- 
effect relationships that need to be investigated. 
● Anyone can submit a report to VAERS including 
health care professionals, vaccine manufacturers, 
vaccine recipients, and parents or family members 
of people who have received a vaccine. 
| questions and answers | 
What is VAERS? 
VAERS is a national vaccine safety surveillance program overseen 
by CDC and FDA. VAERS collects and analyzes reports of adverse 
events that happen after vaccination. Each year, VAERS receives 
around 30,000 reports. Most of these reports describe known, 
mild side effects such as fever. Scientists at CDC and FDA monitor 
VAERS reports closely to identify reported adverse events that need 
to be studied further. Sometimes, it is only after a vaccine has been 
approved and used broadly that rare side effects can be detected by 
monitoring systems such as VAERS. 
How are the VAERS data used? 
VAERS scientists look for unusually high numbers of reports of an 
adverse event after a particular vaccine or a new pattern of adverse 
events. If scientists see either of these situations, focused studies in 
other systems are done to determine if the adverse event is or is not 
a side effect of the vaccine. Information from VAERS and vaccine 
safety studies is shared with the public. Throughout the process of 
monitoring VAERS, conducting studies, and sharing findings, 
appropriate actions are taken to protect the public’s health. 
For example, if VAERS identifies a mild adverse event that is verified 
as a side effect in a focused study, this information is reviewed by 
CDC, FDA, and vaccine policy makers. In this situation, the vaccine 
may continue to be recommended if the disease-prevention benefits 
from vaccination outweigh the risks of a newly found side effect.  
Information about newly found side effects is added to the vaccine’s 
package insert that lists safety information. Newly found side effects 
also are added to the Vaccine Information Statement (VIS) for 
that vaccine. If serious side effects are found, and if the risks of the 
vaccine side effect outweigh the benefits, the recommendation to 
use the vaccine is withdrawn. 
Vaccine Information Statements (VISs) are informa­
tion sheets produced by the Centers for Disease Control 
and Prevention (CDC) that explain to vaccine recipients,
their parents, or their legal representatives both the 
benefits and risks of a vaccine. Federal law requires 
that VISs be handed out whenever (before each dose) 
certain vaccinations are given. 
Adverse events reported to VAERS are not necessarily side effects 
caused by vaccination. An adverse event is a health problem that happens 
after vaccination that may or may not be caused by a vaccine. These events 
may require further investigation. By definition, a side effect has been 
shown to be linked to a vaccine by scientific studies.
Before the FDA licenses (approves) a vaccine for use, the vaccine must be 
tested with volunteers during clinical trials to make sure it is safe and 
effective. Sometimes side effects show up in clinical trials. Most often 
side effects found in clinical trials are minor, such as possible pain at the 
injection site, and the vaccine is licensed because the disease-prevention 
benefits outweigh the risk of getting the side effect.
As part of the United States’ comprehensive vaccine safety monitoring 
system, VAERS detects rare vaccine adverse events, signaling to scientists 
that focused studies are needed to determine whether the adverse event is 































| questions and answers | continued  
Vaccines are tested before they are used, so why are there 
possible unknown side effects? 
When vaccines are ready for tests in humans, they are tested on thou­
sands to tens of thousands of volunteers. However, even this large 
number is not always enough to find rare side effects, such as a one- 
in-a-million side effect. So, VAERS is needed to constantly look for 
possible side effects that might not have been detected previously. 
Are all events reported to VAERS caused by vaccinations? 
VAERS data alone usually cannot be used to answer the question, 
“Does a certain vaccine cause a certain side effect?” This is mainly 
because adverse events reported to VAERS may or may not be caused 
by vaccines. There are reports in VAERS of common conditions that 
are found shortly after vaccination, often related by chance alone, 
and investigations find no medical link between vaccination and 
the condition. 
To know if a vaccine causes a side effect, scientists must know 
whether the adverse event is occurring after vaccination with a 
particular vaccine more often than would be expected without 
vaccination. They also need to consider whether the association 
between the vaccine and the adverse event is consistent with existing 
medical knowledge about how vaccines work in the body.  
Who can report to VAERS? 
Anyone can submit a report to VAERS including parents, patients, 
and health care professionals. Vaccine manufacturers who receive 
reports of adverse events also report the information to VAERS. FDA 
and CDC encourage anybody who experiences any adverse event 
after vaccination to report to VAERS. Individuals completing a report 
can work with a health care professional to make sure they fill out the 
report form completely. By working together, health care profession­
als and patients/parents can provide FDA and CDC with data that 
will be most useful and accurate for examining possible trends. 
Why should I report to VAERS? 
Reporting to VAERS gives valuable information that helps CDC and 
FDA ensure that vaccines are very safe. If a previously unknown 
adverse event does come up, timely reports will help scientists find it 
and determine how to best address the issue. 
How do I report to VAERS? 
Reports can be submitted online, by fax, or by mail. To report to 
VAERS online, go to https://vaers.hhs.gov/esub/step1 and follow the 
5 steps. Or, to print out the form to return it by fax or mail, go to 
https://vaers.hhs.gov/resources/vaers_form.pdf. To request a form by 
phone, call 1-800-822-7967. Forms may be returned by fax to 
1-877-721-0366 or mailed to VAERS, P.O. Box 1100, Rockville, MD 
20849-1100. VAERS staff may call for more information. 
What events should I report to VAERS? 
VAERS encourages the reporting of all adverse events that occur 
after administration of any vaccine licensed in the United States. 
How do I find out if a vaccine adverse event has been 
reported to VAERS? 
VAERS data is available to the public for download at http://vaers. 
hhs.gov/data/index. You may also request information about adverse 
events reported to VAERS by sending a fax to 301-443-1726, by call­
ing 301-827-6500, or by writing to: Food and Drug Administration, 
Freedom of Information Staff (HFI-35), 5600 Fishers Lane, Rockville, 
MD 20857. 
Remember, just because an adverse event or condition has been 
reported does not prove that the adverse event is caused by vaccina­
tion. Parents who are concerned about vaccine side effects should 
talk to their child’s health care professional. 
| the science | 
These articles tell more about VAERS and provide examples 
of the important role it serves as part of the U.S. vaccine 
safety monitoring system.
An Overview of the Vaccine Adverse Event Reporting System 
(VAERS) as a Surveillance System by J.A. Singleton et al. Vaccine. 
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